It seems the content is not visible or provided. Please share the content you'd like summarized, and I'd be happy to help!
NVS has been in the news recently: Novartis AG has bolstered its U.S. pharmaceutical stockpiles in anticipation of potential tariffs under the Trump administration, as stated by CEO Vas Narasimhan. Additionally, the company reported that over 90% of patients with relapsing multiple sclerosis experienced no disease activity after switching to its drug Kesimpta, resulting in a low annualized relapse rate of 0.06.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.